A Bright Solution for Dry Eyes

OptiLight by Lumenis: A Real Solution for Dry Eyes

Meet OptiLight

Innovative light therapy for brighter results

Targets multiple key contributors of dry eyes for lasting results

Finally reduces your dependency on eye drops

Developed with safety in mind, for your peace of mind

What Can I Expect?

Four sessions spaced 2-4 weeks apart. Each session usually takes only 10-15 minutes.

OptiLight is applied on the skin below the eyes and is non-invasive.
Your practitioner will cover your eyes with shields and apply a thin layer of coupling gel on the treatment area.
You may experience a warm sensation as light is applied to the skin. The treatment is gentle with minimal discomfort.
You can return to your daily activities and apply makeup straight away in most cases.
Patients usually report an improvement in symptoms after the second or third session.

Suffering From Dry Eyes?

Join the “NOT GONNA LIVE WITH IT” Generation

Americans are estimated to suffer from dry eye disease - only half are diagnosed ¹


of patients are frustrated by their dry eye condition ²


of patients wish there was something more effective to treat their dry eye ³

1. USA General Population 2018 Cross Sectional Study and Census.gov Population Clock
2. Kheirkhah et al., Patients’ Preceived Treatment Effectiveness in Dry Eye Disease, The Journal of Cornea and External Disease, 2017
3. https://theophthalmologist.com/subspecialties/the-burden-of-dry-eye-disease

Frequently Asked Questions

What is OptiLIGHT?
OptiLIGHT is a light-based treatment that uses precise, intense broad spectrum light to address signs of dry eye disease due to meibomian gland dysfunction (MGD). MGD is the most common cause of dry eye disease, accounting for about 86% of cases.

The treatment addresses inflammation, which is one of the key underlying factors in MGD. OptiLIGHT was specifically developed to reach the delicate contours of the treated area safely, effectively, and gently using the OPT™ technology.

It is intended for use in patients who are at least 22 years old, together with other available treatments, such as Meibomian gland expression, artificial tear lubricants, and warm compresses.

What is the OPT™ technology?
Lumenis’ patented technology OPT™ (Optimal Pulse Technology) transforms the use of light and allows targeted, uniform, precise, and controlled treatment. Specifically designed for the delicate area below the eye, OPT™ safely and effectively breaks the vicious cycle of inflammation associated with dry eye.
How does OptiLIGHT work?
OptiLIGHT is a multi-factorial treatment for a multi-factorial disease. It addresses the disease by reducing major sources of inflammation leading to dry eye disease such as abnormal blood vessels, Demodex mites, and pro-inflammatory agents. OptiLIGHT restores the function of meibomian glands and delays evaporation of the tear film.
What does treatment with OptiLIGHT involve?

Treatment protocol typically consists of 4 sessions, at 2 to 4 weeks apart:

  • During treatment, your practitioner will cover your eyes with shields and apply a thin layer of coupling gel on the treatment area.
  • During treatment, light is applied on the skin below the eyes, most patients report minimal discomfort.
  • OptiLIGHT is followed by meibomian gland expression.
  • Each session takes only 10-15 minutes. There is no downtime, you can resume your daily activities immediately.
When should I expect an improvement?
Patients typically report improvement after 2 to 3 treatments. For optimal results, 4 sessions are advised. To ensure long-term results, a maintenance session is recommended every 6-12 months.
What should I expect after treatment?
You may experience some redness immediately following treatment. This will usually disappear within a few hours. You can return to your daily activities and apply makeup straight away in most cases. You will be advised to stay out of direct sunlight for a few days and to apply sunscreen.
What are the potential risks and side effects?
Potential risks and side effects of using OptiLIGHT on your skin may include pain/ discomfort, damage to natural skin texture, change of pigmentation, scaring, excessive edema, fragile skin, bruising, burns, pruritus and xerosis. You should consult with your physician about these risks and whether treatment with OptiLIGHT is suitable for you.
Is OptiLIGHT treatment suitable for everyone?
Treatment with OptiLIGHT is contraindicated for patients with the following conditions in the treatment area:

Ocular surgery or eyelid surgery or Neuro-paralysis within 6 months prior to the first treatment;
Uncontrolled eye disorders affecting the ocular surface;
Pre-cancerous lesions, skin cancer or pigmented lesions in the planned treatment area;
Uncontrolled infections or uncontrolled immunosuppressive diseases;
Recent Ocular infections;
Prior history of cold sores or rashes in the perioral area, including: Herpes simplex 1 u0026amp; 2, Systemic Lupus erythematosus and porphyria;
Use of photosensitive medication and/or herbs that may cause sensitivity within 3 months prior to the first IPL session;
Recent radiation therapy to the head or neck or planned radiation therapy;
Recent treatment with a chemotherapeutic agent or planned chemotherapy;
History of migraines, seizures or epilepsy.

What Our Patients Are Saying

“My eyes have been dry for 20 years. I thought I’d have to live in misery for the rest of my life, but after my OptiLight treatments, my eyes actually feel normal. I’m like a new person – I can even wear contacts now!”

―Suzanne G.

“I love Dr. Chenoweth! He is the best in the Tulsa area and always makes me feel taken care of without having to jump through hoops. His office has a variety of services, as well.“

―Eden L.

“My husband and I both go to Dr. Chenoweth for our vision needs. I didn’t feel rushed during my visit, and he made sure all our questions were answered. I had OptiLight treatment for my dry eye in the same office!“

―Christina S.

Schedule Your Appointment

Please fill out the form below, and we’ll get in touch with you shortly.

This field is for validation purposes and should be left unchanged.